Beijing ACCB Biotech Overview
- Year Founded
-
2004
- Status
-
Private
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
10
- Investments
-
1
Beijing ACCB Biotech General Information
Description
Developer of molecular diagnostic reagents designed for cancer screening and personalized treatment. The company's platform integrates quantitative PCR, fluorescence in situ hybridization, and next-generation sequencing, enabling the hospital and medical research markets to access cancer screening kits, gene mutation detection reagents, personalized medication tests, prognosis assessment services, molecular diagnostic reagents, and medical testing services.
Contact Information
Website
www.accb.com.cnCorporate Office
- Room 301, Building 1
- Number 103 Beiqing Road, Haidian District
- Beijing, 100048
- China
Corporate Office
- Room 301, Building 1
- Number 103 Beiqing Road, Haidian District
- Beijing, 100048
- China
Beijing ACCB Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Beijing ACCB Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Beijing ACCB Biotech Patents
Beijing ACCB Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019085249-A2 | Primer, probe and test kit used for detecting egfr gene mutation | Inactive | 31-Oct-2017 | ||
| WO-2019085249-A3 | Primer, probe and test kit used for detecting egfr gene mutation | Inactive | 31-Oct-2017 | ||
| WO-2018014519-A1 | Primer, probe and kit used for detecting c-kit gene mutation | Inactive | 18-Jul-2016 | ||
| WO-2017000533-A1 | Primer, probe, and reagent kit for use in detecting mutation in c-kit gene | Inactive | 29-Jun-2015 | ||
| WO-2015192644-A1 | Method and kit for detecting dna methylation | Inactive | 16-Jun-2014 | G01N33/53 |
Beijing ACCB Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Beijing ACCB Biotech Investments (1)
Beijing ACCB Biotech’s most recent deal was a Seed Round with Cordmagic. The deal was made on 21-Mar-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cordmagic | 21-Mar-2019 | Seed Round | Personal Products |
Beijing ACCB Biotech FAQs
-
When was Beijing ACCB Biotech founded?
Beijing ACCB Biotech was founded in 2004.
-
Where is Beijing ACCB Biotech headquartered?
Beijing ACCB Biotech is headquartered in Beijing, China.
-
What industry is Beijing ACCB Biotech in?
Beijing ACCB Biotech’s primary industry is Diagnostic Equipment.
-
Is Beijing ACCB Biotech a private or public company?
Beijing ACCB Biotech is a Private company.
-
What is Beijing ACCB Biotech’s current revenue?
The current revenue for Beijing ACCB Biotech is .
-
Who are Beijing ACCB Biotech’s investors?
PICC TusHoldings Fund, SummitView Capital, Tsinghua Holdings, Sunz Fund, and Topview Innovation are 5 of 6 investors who have invested in Beijing ACCB Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
